CEO: | Jeremy Skillington |
CFO: | Ian O’Connel |
Executive Chairman: | Cathal Friel |
Independent Non-Executive Director: | Edward Gibson |
Independent Non-Executive Director: | Luke O’Neill |
Independent Non-Executive Director: | Brendan Buckley |
Non-Executive Dir: |
Address: | Queen Mary Bioenterprises Innovation Centre, 42 New Road, London, United Kingdom, E1 2AX |
Phone: | +44 (0)20 7183 1499 |
Website: | http://www.poolbegpharma.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BKPG7Z60 |
Currency | UK Pounds |
Share Price | 13.63p |
Change Today | 0.033p |
% Change | 0.25 % |
52 Week High | 14.90 |
52 Week Low | 6.55 |
Volume | 16,707 |
Shares Issued | 500.00m |
Market Cap | £68.17m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
10:09 | 1,476 @ 13.55p |
10:06 | 15 @ 13.69p |
10:04 | 8,908 @ 13.53p |
10:03 | 73 @ 13.69p |
10:02 | 146 @ 13.69p |
CEO | Jeremy Skillington |
CFO | Ian O’Connel |
You are here: research